Related Experiment Video

Updated: Jun 4, 2025

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
07:31

Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity

Published on: August 23, 2022

3.1K

Compound FLZ attenuates neuroinflammation through inhibiting Src/PTEN/Akt signaling pathway

Fang-Fang Li1, Yuan-Peng Zheng1, Gen Li1

  • 1State Key Laboratory of Bioactive Substance and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Journal of Asian Natural Products Research
|January 1, 2025
PubMed

Insights

Compound FLZ offers neuroprotection for Parkinson's disease (PD) by inhibiting the Src/PTEN/Akt pathway. This research clarifies FLZ's mechanism, suggesting its potential for treating PD.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder with limited treatment options.
  • The compound FLZ demonstrates neuroprotective effects, but its mechanism of action in PD is not fully understood.

Purpose of the Study:

  • To elucidate the precise mechanism by which FLZ exerts neuroprotection in Parkinson's disease.
  • To investigate the role of the PTEN/Akt signaling pathway in FLZ's therapeutic effects.

Main Methods:

  • Utilized LPS-challenged BV2 cells to model neuroinflammation.
  • Assessed the effects of FLZ on PTEN/Akt activity, Src phosphorylation, and protein interactions.
  • Investigated the direct binding of FLZ to Src kinase.

Main Results:

  • FLZ decreased PTEN/Akt activity in LPS-challenged BV2 cells.
  • FLZ's suppression of neuroinflammation was dependent on PTEN and Src activity.
  • FLZ directly binds to and inhibits Src kinase activity, thereby attenuating the Src/PTEN/Akt pathway.

Conclusions:

  • FLZ exerts neuroprotective effects against neuroinflammation in Parkinson's disease by directly inhibiting Src kinase.
  • The inhibition of the Src/PTEN/Akt pathway is the key mechanism underlying FLZ's therapeutic potential in PD.
  • FLZ represents a promising therapeutic agent for clinical application in Parkinson's disease treatment.
Keywords:
FLZPTENParkinson’s diseaseSrc tyrosine kinaseneuroinflammation

More Related Videos

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.2K
SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

7.3K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K